PreciseMDX Delivers Record Year-Over-Year Growth Through New Partnerships and Innovation
Company meets growing demand for digital and direct-to-consumer diagnostic testing solutions
LOS ANGELES, November 1, 2022 /PRNewswire/ — PreciseMDXthe leading interoperable digital health platform that automates and simplifies every step of the diagnostic testing experience for labs, providers and patients, continues to disrupt the industry with its commitment to innovation and customer satisfaction.
Since its inception in 2020, the company, which provides a best-in-class platform that facilitates seamless integration with leading EHRs, SILs, and LIMSs, has continuously pioneered new enhancements that support growth, l efficiency, cost transparency and laboratory compliance.
“PreciseMDX has had an exceptional year of growth, over 300% so far, and success fueled by several new developments and important industry partnerships that allow us to further create a comprehensive digital health environment for diagnosis,” said Mark Dorner, Co-founder and CEO. “These innovative solutions and partnerships help labs scale and expand their lab offerings in days, while improving operational and billing efficiencies and delighting providers and patients.”
Over the past year, PreciseMDX has entered into key contractual partnerships with companies such as Mainz Biomed provide direct-to-consumer (DTC) colorectal cancer genetic screenings through Europe; Marker pen, which offers the first salivary swab diagnostic test for concussions; and Organic Galateaan academic laboratory that provides biobanking and ancestry services and solutions for clinical data with a focus on United States and Latin America.
With more than 70% of all medical and healthcare decisions based on diagnostic test items according to the CDC, partnerships like these have a significant impact on patient care.
“Our society is changing the way people live. It’s critical that all patients, wherever they live, have timely access to the diagnostic tests needed to ensure better outcomes,” Dorner said. “Many companies are now recognizing this and, as a result, providing more preventive and diagnostic health benefits to their employees. Proactive care leads to better health, and PreciseMDX provides the innovation that increases access to testing and execution delay.
In an effort to provide better transparency and efficiency to its customers, PreciseMDX has launched the PMDX Test Tracker, a tool within the platform that provides real-time visibility for patients and providers to stay informed at every stage of the test cycle. test. They also developed the PMDX Good Faith Estimator in accordance with the law with no surprises, so that patients are informed in advance of all testing costs. This saves order providers and labs time that was previously spent processing patient billing requests.
With a focus on delivering clean data, PreciseMDX also reduces errors and unnecessary duplication of testing. The PMDX EHR Connector, another enhancement released this year, enables one-click lab orders, integration with major EHRs, automated test results, and a timely billing and revenue cycle to provide a streamlined experience for laboratories and order suppliers.
Going forward, the company will continue to seek new partnerships through United States and internationally to meet growing demand and meet the increased diagnostic testing needs of ordering healthcare providers.
For more information on PreciseMDX and the guiding principles that enable the company to solve the most important problems, visit PreciseMDX.com.
PreciseMDX empowers and connects labs, providers, and patients with a cutting-edge platform that integrates laboratory information management systems (LIM), EHRs, clearinghouses, and biotech companies for a better experience healthier patients and outcomes. The comprehensive, interoperable platform scales to any lab, any test, any population, and any volume with highly customizable, paperless patient journeys, powerful automation, transparent good faith estimates and seamless ecosystem integration. Leveraging more than 30 years of expertise in digital healthcare transformation, PreciseMDX works with customers around the world to help them serve more than eight million patients in the United States, Swiss, Germanyand Canada.
For more information